Physician profile
Jeffrey Edward Stych
NPI 1275984353
$16,181.95
in general payments reported to CMS, 2019-2025
31 companies · $2,914 in 2025
The $2,914 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $4,031 · 2021: $436 · 2022: $2,036 · 2023: $4,451 · 2024: $1,573 · 2025: $2,914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,060 · Travel and Lodging: $3,710 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,059.62 |
| Travel and Lodging | $3,710.15 |
| Education | $168.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,908.72 | 2020-2023 | |
| Paragon 28, INC. | $1,974.61 | 2019-2025 | Grappler, Portfolio, Bun-Yo-Matic |
| Vilex LLC | $1,856.08 | 2025 | Redemption |
| Medwest Associates | $1,576.04 | 2023 | |
| Organogenesis INC. | $1,352.48 | 2019-2025 | Affinity, Puraply, Apligraf |
| Epsfl, LLC | $997.97 | 2023 | |
| Stryker Corporation | $819.63 | 2019-2025 | Citrefix, Phalinx, Augment Injectable |
| Convatec INC. | $775.92 | 2023-2025 | |
| Integra Lifesciences Corporation | $590.57 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $380.47 | 2019-2024 | Pico, Q-Fix, Healicoil |
| Horizon Therapeutics Plc | $369.65 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $347.95 | 2022-2025 | Diamondback Peripheral, Diamondback Coronary, Proclaim |
| Treace Medical Concepts, INC. | $332.64 | 2023-2025 | |
| Amgen INC. | $283.13 | 2024-2025 | Krystexxa |
| Bard Peripheral Vascular, INC. | $229.74 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $192.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Linvatec Corporation | $177.75 | 2023 | Fracture and Correction Colag 2, Colink Plating System, Colink 2 |
| Medline Industries Lp | $159.20 | 2022 | |
| Depuy Synthes Sales INC. | $134.94 | 2022 | |
| Sanara Medtech INC. | $132.34 | 2023 | Celleraterx |
| Biopoly LLC | $116.85 | 2023 | |
| Acell, INC. | $101.43 | 2019 | |
| Acera Surgical, INC. | $69.28 | 2022 | |
| Cardiovascular Systems INC. | $65.60 | 2022 | |
| Abbvie INC. | $65.18 | 2025 | |
| Mimedx Group, INC. | $46.89 | 2025 | |
| Bioventus LLC | $40.22 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $27.03 | 2022 | |
| Inari Medical, INC. | $21.01 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Radius Health, INC. | $20.21 | 2024 | Tymlos |
| Baxter Healthcare | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Stych listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.